PETS — PETMED EXPRESS INC
—
Nasdaq ·
Consumer Staples ·
Drug Retail ·
CIK 1040130 ·
Last close
$1.53
Market Cap
$33.17M
52W High
$4.10
52W Low
$1.53
ADV30
117,803
Next earnings
2026-11-16
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 41,015,000 | 11,333,000 | -6,232,000 | -6,145,000 | 63,762,000 | 13,079,000 | 40,773,000 |
| Mar 2026 | 42,817,000 | 13,942,000 | -5,692,000 | -4,061,000 | 81,191,000 | 21,412,000 | 52,251,000 |
| Dec 2025 | 40,660,000 | 9,456,000 | -10,469,000 | -10,553,000 | 87,965,000 | 26,914,000 | 55,199,000 |
| Sep 2025 | 44,364,000 | 12,415,000 | -8,380,000 | -8,520,000 | 100,301,000 | 36,098,000 | 57,237,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-28,394,000
Investing CF
$-4,615,000
Financing CF
$-299,000
CapEx
$-5,413,000
Dividends Paid
$-21,000
Buybacks
—
EPS Diluted TTM
$-2.75
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$9,263,000
Inventory
$13,608,000
Receivables
$1,908,000
ST Investments
—
EBIT TTM
$-31,415,000
Pretax Income TTM
$-57,359,000
Interest Exp TTM
—
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$168,856,000
EBITDA
$-18,588,000
Free Cash Flow
$-15,951,500
Enterprise Value
$22,079,982
Total Cash
$13,079,000
Total Debt
$414,000
Shares Out
21,678,914
Trailing EPS
$-1.37
Book Value
$1.09
ROE
-78.6%
ROA
-20.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 179,021,000 | -31,415,000 | -57,286,000 | 81,191,000 | 52,251,000 | 28,940,000 | -28,394,000 |
| Mar 2025 | — | — | — | — | — | — | — |
| Mar 2024 | 274,095,000 | -8,162,000 | -7,464,000 | 169,884,000 | 73,153,000 | 96,731,000 | 4,317,000 |
| Mar 2023 | 247,569,000 | 6,051,000 | 5,140,000 | 167,478,000 | 57,512,000 | 109,966,000 | 27,803,000 |
| Mar 2022 | 272,282,000 | 24,290,000 | 18,716,000 | 179,698,000 | 56,248,000 | 123,450,000 | 18,498,000 |
TTM Snapshot
Revenues TTM
$241,542,000
NetIncome TTM
$-367,000
OpCashFlow TTM
$0
Assets (Latest)
$148,700,000
Forward EPS
$-0.03
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $2.50 · spot: $1.53 · call volume: 115 · put volume: 4
Expected Move to 2026-12-18:
±$0.93
(60.78%) —
implied range
$0.60 –
$2.46
· ATM straddle on $2.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| YI | 111, Inc. | $18.71M | $3.60 | — |
| RDGT | Ridgetech Inc. | $3.01M | $0.83 | — |
| GRDN | Guardian Pharmacy Services, Inc. | $2.05B | $41.21 | — |
| CVS | CVS HEALTH Corp | $113.99B | $89.13 | — |
| CANN | TREES Corp (Colorado) | — | $nan | — |
News headlines (Yahoo Finance, 1h cache)
PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director
2026-09-21 12:30 · Yahoo
PetMed Express (PETS) Q1 2027 Earnings Call Transcript
2026-08-20 22:58 · Yahoo
PetMed Express Q1 Earnings Miss Estimates, Sales Decline Y/Y
2026-08-14 15:33 · Yahoo
PetMed Express Inc (PETS) (Q1 2027) Earnings Call Highlights: Narrowing Losses and Strategic ...
2026-08-14 05:03 · Yahoo
PetMeds® Announces First Quarter Financial Results
2026-08-13 20:05 · Yahoo
PetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026
2026-07-30 12:00 · Yahoo
SilverCape Releases Revised Proposal to Acquire PetMed Express for $3.00 per Share in Cash
2026-06-29 11:08 · Yahoo
What makes PetMed Express, Inc. (PETS) one of the Best Pet Care Stocks to Buy for Consistent Recurring Revenue?
2026-06-22 13:31 · Yahoo
PetMed Express Inc (PETS) Q4 2026 Earnings Call Highlights: Navigating Challenges and Embracing ...
2026-06-03 05:00 · Yahoo
PetMed Express (PETS) Q4 2026 Earnings Transcript
2026-06-03 00:52 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.